Participants & recruitment
seizures, epilepsy, cognitive impairment, TVT, neurological disorder, dementia, depressive disorder, PD, migraines, Parkinson’s, Dementias
EPILEPSY, NEUROLOGICAL DISORDER, MIGRAINES, MOTION SICKNESS, MOVEMENT DISORDERS, NEURODEGENERATIVE DISEASES
Participants in this pilot study were recruited from a cross-over subset of a larger single-centre pilot randomised controlled trial exploring the feasibility and effectiveness of TVT compared with standard care, in people with PD [Participants were recruited from Movement Disorders Clinics at the Northumbria Healthcare NHS Foundation Trust, Parkinson’s UK Research Support Network, and Dementias & Neurodegenerative Diseases Research Network. Eligibility for the trial meant that study participants had a confirmed diagnosis of PD, were aged over 50 years, living independently, and able to walk and stand without assistance. Exclusion criteria included a history of epilepsy, seizures, migraines, severe motion sickness or sensitivity to light (due to the use of stroboscopic glasses). In addition, individuals with a history of depressive disorder, diagnosis of dementia, or other severe cognitive impairment which would mean they were unable to comply with testing procedures, were not recruited. Individuals with any acute musculoskeletal conditions, unstable medical conditions, or any neurological disorder other than PD were also not eligible.